More from the article...

..."These vouchers are non-transferrable," an FDA spokesperson told Fierce Biotech. "However, they will remain valid through changes in company ownership."

FDA Commissioner Marty Makary, M.D., will determine a company's eligibility for CNPV by assessing whether the biopharma is addressing several national priorities. ...

So, Pres Trump seems to be inserting himself into the FDA drug approval process?

What might that mean?